Click here to download Beckman Coulter-Immunoassay-Quick-reference-guide-parameters

Access BNP reflects cardiac status and effects of therapy
Access BNP joins other Beckman Coulter cardiovascular diseases (CVD) assays, such as Access hsTnI, the first FDA-approved high sensitivity troponin I assay, AccuTnI+3 (Troponin I), CK-MB (Creatine Kinase MB), Myoglobin and Digoxin.
“BNP is a protein secreted by the ventricular musculature in response to volume or pressure overload on the heart. This is an important biomarker in the diagnosis of heart failure (HF)iii and left ventricular dysfunction” said Dr.Anagh Vora, chief medical officer, Beckman Coulter. This high-performance assay can be used across all Beckman Coulter immunoassay analyzers, including, Access 2, DxI 600 and DxI 800                                                                                               LEARN MORE
                                                                                                                                         

 

NEW: Beckman Coulter SARS-CoV-2 Antigen Test 
Beckman Coulter’s SARS-CoV-2 Antigen Test Makes Large-scale, Serial Testing Programs Feasible
This test will help with the roll-out of mass testing in environments where people come together, such as schools, businesses, hospitals and communities. Results of the Beckman Coulter antigen test can be delivered in 30 minutes on the immunoassay analyzers Unicel DxI 800, with a testing throughput of 200 samples per hour.

READ MORE             SEE ALSO BECKMAN COULTER  COVID-19 PROTOFOLIO 

Beckman Coulter SARS-CoV2 IgM Antibody Test

In general virus infection behavior, an IgM assay will give information about current or recent infection; while IgG will, in addition, also give information about a more sustainable immune response.These two pieces of the infection story blur together when the patient takes a combined, or total IgM and IgG test. Because seroconversion is such a highly individualized journey, separate SARS-CoV-2 IgM and IgG tests can provide greater insight into where the patient is at in their infection timeline

READ MORE :      Individual SARS-CoV-2 IgM Antibody Testing         SARS-COV-2 IgG/IgM

Beckman Coulter SARS-CoV2  IgG Antibody Test 

READ MORE :  
SARS- CoV2 IgG Assay - Beckman Coulter - General Brochure
SARS- CoV2 IgG Assay - Beckman Coulter : need for efficiency SARS-CoV2
SARS- CoV2 IgG Assay - Benefits of a stand alone IgG assays vs.a combined IgM/IgG Assay
SARS- CoV2 IgG Assay - The medical value of Spike Protein

LOW VOLUME

Exceptional productivity in a compact design
Reliability matters. This benchtop immunoassay analyzer fits labs with space constraints and delivers fast, reliable results.
Learn more
 ANNUAL TEST VOLUME     <40,000
 THROUGHPUT                       Up to 100 tests/hour 

MID VOLUME

Simplicity matters. This immunoassay analyzer gives technologists the benefit of ease of use without sacrificing throughput.

Learn more
 ANNUAL TEST VOLUME     40,000 to 80,000
 THROUGHPUT                      Up to 200 tests/hour 

HIGH VOLUME

Scalability matters. This immunoassay system supports the expanding needs of your growing laboratory.

Learn more
ANNUAL TEST VOLUME    >80,000
THROUGHPUT                     Up to 400 tests/hour